Since its inception, biotechnology has been preoccupied with virus filtration, the clearance of invasive and adventitious viruses from biopharmaceutical products. And now, far from waning, virus filtration is set to become even more important. Virus filtration, reports Markets and Markets, constitutes a global market that is growing 12% each year. At present, this market is valued at $1.8 billion. By 2020, it will reach $3.3 billion.
GSK will inaugurate its newest global vaccines research and development (R&D) center in Rockville, Maryland, further strengthening and expanding its vaccines presence in the USA. Up to 200 new jobs will be created at the Rockville facility, with GSK investing over $50 million in the next two years to continue to develop the site with latest state-of-the-art scientific research technology and equipment.
Inova Health System, the giant nonprofit hospital network serving Northern Virginia, is creating a new start-up incubator and investment program focusing on “personalized” medicine innovations.
Executives say they plan to invest at least $100 million over the next three to five years making $2 million to $5 million bets on promising young companies with products that have gained some traction in the marketplace.
Craig Sager II is a managing editor and sportswriter based in Atlanta covering high school sports as well as working with the Atlanta Journal Constitution and the Atlanta Falcons. ‘What I can do and what anyone can do is bring the same passion into each day that he did.’
Russ Ramsey, Peter Scher and Ted Leonsis have joined with 14 other CEOs to create the Greater Washington Partnership to boost the regional economy and tackle transportation issues. It joins several other business groups with similar goals, though its focus will be on the broader region from Baltimore to Richmond.
Major industries from retail to aeronautics are leveraging big data. But despite the abundance of data in healthcare, and the clear promise of big-data analytics, the sector has been slow to put it to work. Among the obstacles to adoption are laws aimed at protecting patient information, and a shortage of technical talent; hospitals and clinics compete for big data engineers whose technical skills can be agnostically applied across industries. Nonetheless, in 2015 Geisinger Health System implemented an IT system called a Unified Data Architecture (UDA) which allowed us to integrate big data into our existing data analytics and management systems.
Few people realize that the world’s biggest early stage investment fund in the NIH. Unlike most investors, every penny you get, if you should be so lucky, is non-dilutive. That is not to say there are no strings attached and that the funding is not tranched, but scores of products we see day in and day out, from blockbuster drugs, vaccines, medical devices to health IT benefitted from your US tax dollars at work.
While technology is no silver bullet able to solve all that ails the healthcare industry, it has always been part and parcel of any revolution.
Think of the printing revolution and its influence of the Protestant Reformation that forever created a breach in the Catholic church.
Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces that C. Eric Winzer, M.B.A., currently serving Immunomic as Chief Financial Officer, will join the Board of Directors.
“Mr. Winzer’s keen financial expertise and broad industry experience will be a valuable addition to the Immunomic Board of Directors,” announced Immunomic CEO, Dr. William Hearl. “The Board has appreciated his prior contribution to our meetings and we are pleased to formally add him to this important advisory team.”
The Inova Health System have launched Inova Strategic Investments and the Inova Personalized Health Accelerator. Inova Strategic Investments will invest in healthcare venture funds as well as make direct investments in companies. IPHA will accept six to eight companies per year, providing education and funding. Hooks Johnston and Peter Jobse have been named managing directors of these new Inova vehicles.
